An unusual case of Asherman’s syndrome in a virgin menopausal woman

Panayotidis, Costas; Ranjit, Raj

doi:10.1007/s10397-003-0004-x

Cited by 6 publications

(5 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, as the drug-induced oestrogen deficiency progresses, the endometrium atrophies and may be damaged more easily as fibroids are separated from the overly thinned endometrium. Hypogonadotrophic hypogonadism has been shown to be associated with extensive IUA formation and so-called 'senile' adhesions have been found in post-menopausal women who had no prior instrumentation (Buttram and Turati, 1977;Panayotidis and Ranjit, 2002). The best of both worlds may be achieved by scheduling the myomectomy 7-8 weeks after the last injection of a medication such as depot leuprolide acetate.…”

Section: Gonadotrophin-releasing Hormone Agonistmentioning

confidence: 99%

Management of Asherman’s syndrome

March

2011

Reproductive BioMedicine Online

264

191

View full text Add to dashboard Cite

Intrauterine adhesions (IUA) or Asherman's syndrome is a multifaceted condition which is being diagnosed with increasing frequency. Although it usually occurs following curettage of the pregnant or recently pregnant uterus, any uterine surgery can lead to IUA. Most women with IUA have amenorrhoea or hypomenorrhoea, but some have normal menses. Those who have amenorrhoea may also have cyclic pelvic pain secondary to 'trapped' menses and the accompanying retrograde menstruation may lead to endometriosis. In addition to menstrual disorders, most women with IUA will present with infertility or recurrent spontaneous abortion. Over the last four decades hysteroscopy has become the standard method to diagnose and treat this condition. Various techniques for adhesiolysis and for prevention of scar reformation have been advocated. The most efficacious appears to be the use of miniature scissors for adhesiolysis and the placement of a balloon stent inside the uterus immediately after surgery. Post-operative oestrogen therapy is prescribed in order to stimulate endometrial regrowth. Follow-up studies to assure resolution of the IUA are mandatory before the patient attempts to conceive as is careful monitoring of pregnancies for cervical incompetence, placenta accreta and intrauterine growth restriction.

show abstract

Section: Gonadotrophin-releasing Hormone Agonistmentioning

confidence: 99%

Management of Asherman’s syndrome

March

2011

Reproductive BioMedicine Online

264

191

View full text Add to dashboard Cite

show abstract

“…21 Other causes include schistosomiasis, 22 Müllerian malformations, atrophy due to a long period of lactation 23 or menopause. 24 3. Idiopathic cause when no apparent reason is found.…”

Section: Etiologymentioning

confidence: 99%

Reproductive Outcome following Hysteroscopic Adhesiolysis in Patients with Asherman's Syndrome

O¹

2011

WJOLS

View full text Add to dashboard Cite

“…-Pathophysiological disturbance such as endometritis, complete miscarriage, septic abortion, uterine tuberculosis [9,10] Müllerian malformations, atrophy due to a long period of lactation [11] or menopause [12] -Idiopathic when no apparent reason is found.…”

Section: Etiology Risk and Associate Factorsmentioning

confidence: 99%

Intrauterine adhesions (IUA): has there been progress in understanding and treatment over the last 20 years?

et al. 2008

View full text Add to dashboard Cite

We review the current evidence about the treatment modalities of intrauterine adhesions (IUA) or Asherman's Syndrome (AS). Systematic approach, audit and well-structured research is mandatory in order to establish the best treatment for the individual needs of patients. The clinical practice changed significantly over the last 20 years with technological advances in hysteroscopy and imaging techniques. Hysteroscopic treatment seems effective and safe. IUA or AS is a rather uncommon finding in general gynaecological practice. The referral to a tertiary centre will help to centralise the most difficult cases and create the opportunity to study more in detail the efficacy of each treatment modality and to compare the different treatment techniques.

show abstract

An unusual case of Asherman’s syndrome in a virgin menopausal woman

Abstract: Absract We present here a case of Asherman's syndrome in a 52-year-old menopausal woman referred to our clinic for postmenopausal bleeding. This case demonstrates a very unusual combination of postmenopausal intrauterine adhesions and ovarian tumour.

Cited by 6 publications

References 4 publications

Management of Asherman’s syndrome

Management of Asherman’s syndrome

Reproductive Outcome following Hysteroscopic Adhesiolysis in Patients with Asherman's Syndrome

Intrauterine adhesions (IUA): has there been progress in understanding and treatment over the last 20 years?

Contact Info

Product

Resources

About